G6PD and Miyoshi myopathy: MTT assays (Fig. 2b) and growth curves (Additional file 2: Fig. S1a, b) demonstrated notably enhanced cellular viability in the G6PD-OE MM cells relative to the wildtype (WT) MM cells (p < 0.05).